Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
Giulia SaturiFernando De FrutosMaurizio SguazzottiEsther Gonzalez-LopezElena NardiFernando DomínguezAlberto PonzianiEva CabreraAngelo Giuseppe CaponettiSara LozanoPaolo MassaMarta Cobo-MarcosAntonella AcciettoVictor Castro-UrdaAlessandro GiovannettiJorge ToqueroChristian GagliardiManuel Gómez-BuenoRafael Rios-TamayoElena BiaginiJavier SegoviaNazzareno GalièPablo García-PavíaSimone LonghiPublished in: Heart (British Cardiac Society) (2023)
Conduction system disease requiring PPM is a common complication in CA that affects up to 20.6% of patients. QRS duration and IVS thickness are independently associated with PPM implantation. A PPM implantation at 12 months model was devised and validated to identify patients with CA at higher risk of requiring a PPM and who require closer follow-up.